⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
CHRS News
Coherus Oncology, Inc. Common Stock
Loqtorzi (toripalimab-tpzi: Inovio Pharmaceuticals, Coherus BioSciences) Market Research Report 2026: Epidemiology, Pipeline Analysis, Insights & Forecasts, 2020-2025, 2025-2030F, 2035F
globenewswire.com
INO
CHRS
Loqtorzi (toripalimab-tpzi: Inovio Pharmaceuticals, Coherus BioSciences) Market Research Report 2026: Epidemiology, Pipeline Analysis, Insights & Forecasts, 2020-2025, 2025-2030F, 2035F
globenewswire.com
INO
CHRS
Form 8-K
sec.gov
CHRS
Coherus Oncology Reports Full Year and Fourth Quarter 2025 Financial Results and Provides Business Update
globenewswire.com
CHRS
Coherus Oncology Reports Full Year and Fourth Quarter 2025 Financial Results and Provides Business Update
globenewswire.com
CHRS
Coherus Oncology to Report Full Year and Fourth Quarter 2025 Financial Results on March 9, 2026
globenewswire.com
CHRS
Coherus Oncology to Report Full Year and Fourth Quarter 2025 Financial Results on March 9, 2026
globenewswire.com
CHRS
Keros Therapeutics Appoints Charles Newton to its Board of Directors
globenewswire.com
KROS
LYEL
CHRS
Age Related Macular Degeneration Market to Reach $16.2 billion by 2033, Globally, by 2034 at 5% CAGR: Allied Market Research
prnewswire.com
REGN
NVS
ROG
BIIB
CHRS
SNY
APLS
BHC
IONS
Coherus Oncology to Participate in Upcoming Investor Conferences
globenewswire.com
CHRS